國立高雄大學圖資館 |

Language: English

Back

Tumor angiogenesisa key target for c...

Marme, Dieter.

Tumor angiogenesisa key target for cancer therapy /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Tumor angiogenesisedited by Dieter Marme.
Reminder of title:	a key target for cancer therapy /
other author:	Marme, Dieter.
Published:	Cham :Springer International Publishing :2019.
Description:	xxii, 681 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eReference
Subject:	TumorsGrowth.
Online resource:	https://doi.org/10.1007/978-3-319-33673-2
ISBN:	9783319336732$q(electronic bk.)

Tumor angiogenesisa key target for cancer therapy /
Tumor angiogenesisa key target for cancer therapy /[electronic resource] :edited by Dieter Marme. - Cham :Springer International Publishing :2019. - xxii, 681 p. :ill., digital ;24 cm.

This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.

ISBN: 9783319336732$q(electronic bk.)

Standard No.: 10.1007/978-3-319-33673-2doiSubjects--Topical Terms:

492397
Tumors
--Growth.

LC Class. No.: RC256 / .T866 2019

Dewey Class. No.: 616.994

Tumor angiogenesisa key target for cancer therapy /
LDR:01859nmm a2200325 a 4500 001 586625
003 DE-He213
005 20200902113643.0
006 m d
007 cr nn 008maaau
008 210326s2019 sz s 0 eng d
020 $a 9783319336732$q(electronic bk.)
020 $a 9783319336718$q(paper)
024 7 $a 10.1007/978-3-319-33673-2 $2 doi
035 $a 978-3-319-33673-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC256 $b .T866 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
090 $a RC256 $b .T925 2019
245 0 0 $a Tumor angiogenesis $h [electronic resource] : $b a key target for cancer therapy / $c edited by Dieter Marme.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xxii, 681 p. : $b ill., digital ; $c 24 cm.
520 $a This exhaustive work shows that new therapies using anti-angiogenic drugs are of particular importance because they can be used against many different types of cancer, as tumor angiogenesis seems to be involved in most if not all solid metastasizing malignancies. The first part of this book summarizes the knowledge acquired on the molecular entities that play a role in tumor angiogenesis and their mechanisms of action. Furthermore, the identification of molecular markers and their validation as predictive and/or prognostic tools is reviewed. In the second and most important part, the clinical applications of anti-angiogenic treatments are documented for a wide variety of tumors. In particular, the modes of combination with other targeted and/or cytotoxic cancer therapies are presented.
650 0 $a Tumors $x Growth. $3 492397
650 0 $a Cancer $x Treatment. $3 252269
650 0 $a Oncology. $3 195181
650 0 $a Medicine. $3 193819
650 0 $a Toxicology. $3 206218
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Pharmacology/Toxicology. $3 273652
700 1 $a Marme, Dieter. $3 275875
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eReference
856 4 0 $u https://doi.org/10.1007/978-3-319-33673-2
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Reference Module Biomedical and Life Sciences (SpringerNature-43744)